Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer.

Marcus DM, Rossi PJ, Nour SG, Jani AB.

Urology. 2014 Jul;84(1):132-7. doi: 10.1016/j.urology.2014.03.012. Epub 2014 Apr 29.

PMID:
24785987
[PubMed - in process]
2.

Clinically Significant Difference in Prostate Localization Using Daily Cone Beam CT (CBCT) and Electromagnetic Transponders.

Khan MK, Das S, Ogunleye T, Jani AB, Rossi P, Shelton J, Liu T.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S15. doi: 10.1016/j.prro.2013.01.056. Epub 2013 Mar 25. No abstract available.

PMID:
24674493
[PubMed]
3.

Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate.

Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):e157-64. doi: 10.1016/j.prro.2013.01.003. Epub 2013 Feb 21.

PMID:
24674413
[PubMed]
4.

Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

Schuster DM, Nieh PT, Jani AB, Amzat R, Bowman FD, Halkar RK, Master VA, Nye JA, Odewole OA, Osunkoya AO, Savir-Baruch B, Alaei-Taleghani P, Goodman MM.

J Urol. 2014 May;191(5):1446-53. doi: 10.1016/j.juro.2013.10.065. Epub 2013 Oct 19.

PMID:
24144687
[PubMed - indexed for MEDLINE]
5.

The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate.

Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB.

Cancer. 2013 Sep 15;119(18):3272-9. doi: 10.1002/cncr.28185. Epub 2013 Jul 1.

PMID:
23818401
[PubMed - indexed for MEDLINE]
6.

Therapeutic options for a rising PSA after radical prostatectomy.

Carthon BC, Marcus DM, Herrel LA, Jani AB, Rossi PJ, Canter DJ.

Can J Urol. 2013 Jun;20(3):6748-55. Review.

PMID:
23783041
[PubMed - indexed for MEDLINE]
Free Article
7.

Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy.

Wang Y, Liu T, Rossi PJ, Watkins-Bruner D, Hsiao W, Cooper S, Yang X, Jani AB.

J Sex Med. 2013 Aug;10(8):2108-14. doi: 10.1111/jsm.12215. Epub 2013 Jun 6.

PMID:
23742221
[PubMed - in process]
8.

Severe lack of comprehension of common prostate health terms among low-income inner-city men.

Wang DS, Jani AB, Tai CG, Sesay M, Lee DK, Goodman M, Echt KV, Kilbridge KE, Master VA.

Cancer. 2013 Sep 1;119(17):3204-11. doi: 10.1002/cncr.28186. Epub 2013 Jun 3.

PMID:
23733135
[PubMed - indexed for MEDLINE]
9.

Comparison of Image-guided Radiotherapy Technologies for Prostate Cancer.

Das S, Liu T, Jani AB, Rossi P, Shelton J, Shi Z, Khan MK.

Am J Clin Oncol. 2013 Feb 20. [Epub ahead of print]

PMID:
23428948
[PubMed - as supplied by publisher]
10.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy.

Ali AN, Rossi PJ, Godette KD, Martin D, Liauw S, Vijayakumar S, Cooper S, Jani AB.

Pract Radiat Oncol. 2013 Jan-Mar;3(1):e1-9. doi: 10.1016/j.prro.2012.04.005. Epub 2012 May 10.

PMID:
24674267
[PubMed]
11.

Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer.

Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB.

J Am Coll Radiol. 2013 Feb;10(2):128-34. doi: 10.1016/j.jacr.2012.06.014. Epub 2012 Dec 12.

PMID:
23245437
[PubMed - indexed for MEDLINE]
12.

Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk.

Marcus DM, Jani AB, Rossi PJ.

Cancer. 2013 Mar 15;119(6):1284. doi: 10.1002/cncr.27879. Epub 2012 Dec 11. No abstract available.

PMID:
23233231
[PubMed - indexed for MEDLINE]
Free Article
13.

Salvage therapy for locally recurrent prostate cancer after radiation.

Marcus DM, Canter DJ, Jani AB, Dobbs RW, Schuster DM, Carthon BC, Rossi PJ.

Can J Urol. 2012 Dec;19(6):6534-41. Review.

PMID:
23228288
[PubMed - indexed for MEDLINE]
14.

Feasibility of accelerated partial breast irradiation in a large inner-city public hospital.

Amin M, Gabram S, Bumpers H, Landry J, Jani AB, Diaz R, Rizzo M.

Ann Surg Oncol. 2012 Dec;19(13):4094-8. doi: 10.1245/s10434-012-2444-x. Epub 2012 Jun 26.

PMID:
22732836
[PubMed - indexed for MEDLINE]
15.

A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008.

Marcus DM, Goodman M, Jani AB, Osunkoya AO, Rossi PJ.

Prostate Cancer Prostatic Dis. 2012 Sep;15(3):283-8. doi: 10.1038/pcan.2012.4. Epub 2012 Feb 21. Review.

PMID:
22349984
[PubMed - indexed for MEDLINE]
16.

High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes.

Edelman S, Liauw SL, Rossi PJ, Cooper S, Jani AB.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1473-9. doi: 10.1016/j.ijrobp.2011.10.036. Epub 2012 Jan 13.

PMID:
22245201
[PubMed - indexed for MEDLINE]
17.

Observations on prostate intrafraction motion and the effect of reduced treatment time using volumetric modulated arc therapy.

Shelton J, Rossi PJ, Chen H, Liu Y, Master VA, Jani AB.

Pract Radiat Oncol. 2011 Oct-Dec;1(4):243-50. doi: 10.1016/j.prro.2011.02.008. Epub 2011 May 14.

PMID:
24674002
[PubMed]
18.

American Radium Society 92nd Annual Meeting.

Jani AB, Le QT, Michalski JJ, Sawaya R, Wilson LD.

Expert Rev Anticancer Ther. 2010 Aug;10(8):1183-5. doi: 10.1586/era.10.109.

PMID:
20735305
[PubMed - indexed for MEDLINE]
19.

External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS).

Malik R, Jani AB, Liauw SL.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1080-6. doi: 10.1016/j.ijrobp.2010.03.040. Epub 2010 Jul 17.

PMID:
20643513
[PubMed - indexed for MEDLINE]
20.

Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease.

Hsiao W, Moses KA, Goodman M, Jani AB, Rossi PJ, Master VA.

J Urol. 2010 Aug;184(2):512-8. doi: 10.1016/j.juro.2010.04.010. Epub 2010 Jun 17.

PMID:
20620410
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk